NASPGHAN Clinical Practice Guideline for the Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease in Children: Recommendations from the Expert Committee on NAFLD (ECON) and the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN).
Level 5 - mechanism / opinion, no new human data
Clinical practice guideline and expert narrative review without systematic review methodology described in the abstract.
PubMed 28107283 · doi:10.1097/MPG.0000000000001482
What was done
An expert committee from the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN) reviewed and summarized available literature to formulate clinical practice recommendations for screening, diagnosing, and managing nonalcoholic fatty liver disease (NAFLD) in children.
What was found
The abstract reports no numerical data or specific recommendations, stating only that guidelines were formulated to direct screening and clinical care.
Why it matters
As pediatric NAFLD has become the most common chronic liver disease in children, these guidelines provide standardized guidance for general pediatricians, subspecialists, and health systems.
Limits
The abstract provides no details on search methodology, inclusion criteria, recommendation consensus process, or quantitative findings.
Cited by
- contradicts Non-alcoholic fatty liver disease affects 45% of American adults.